Seite 1 – Lebenslauf von Fischer Gabriele

E U R O P A S S C U R R I C U L U M V I T A E

PERSONAL INFORMATION

name Univ. Prof. Dr. Gabriele Fischer

address privat Kochgasse 3-5/12a, 1080 Wien, Austria

address work Medical University of Vienna

Center for Public Health

Department of Psychiatry & Psychotherapy

Währinger Gürtel 18-20, 1090 Vienna, Austria

phone 0043 1 40400 21170

fax 0043 1 40400 36290

e-mail gabriele.fischer@meduniwien.ac.at

home page www.sucht-news.at

nationality Austria

date of birth 27.01.1960

WORK EXPERIENCE

since 2013 European Monitoring Center for Drugs and Drug Addiction (EMCDDA) Member of scientific board

since 2011 Center for Public Health Medical University Vienna

Kinderspitalgasse 15, 1090 Vienna Project Leader „Addiction in Public Health“

since 01.10.2000 Department of Psychiatry & Psychotherapy, Medical University of Vienna Spitalgasse 23, 1080 Vienna

Professor for Psychiatry – Addiction Research and Treatment Medical Director of Addiction Clinic

since 2000 Austrian Federal Ministry of Health

Austrian Medical Advisory Council Member

since 2000 UNODOC and WHO Consultant

from 1992 – to 2000 Department of Psychiatry & Psychotherapy, Medical University of Vienna

Head of Units

from 01.03.1992 to 28.02-1995

Department of Psychiatry & Psychotherapy, Medical University of Vienna Co-director: Intensive care Unit (emergency)

from 01.01.1993 to 01.10.1994 Department of Psychiatry & Psychotherapy, Medical University of Vienna

Seite 2 – Lebenslauf von Fischer Gabriele

Director: Forensic Addiction Clinic

from 31.12.1991 to 01.01.1992 Department of Psychiatry & Psychotherapy, Medical University of Vienna Co-Director: Behavioural Therapy Unit

since 1991 Licenced Specialist as Psychiatrist & Neurologist

from 1986 to 1990 Department of Psychiatry & Psychotherapy, Medical University of Vienna Residency in Psychiatry

from 01.05.1989-30.10.1989 Department of Neurology, Medical University of Vienna Residency in Neurology

from 1987 to 1989 Washington University, Department of Psychiatry, St. Louis, USA

Visiting fellow, research education in epidemiology, basic neuroscience & statistics with a focus in addiction psychiatry & personality disorders

from 01.01.1985 to 31.03.1986 II. Internal Medical University Clinic, Vienna

Residency in Internal Medicine

from 01.05.1984 to 31.12.1984 Department of Child and Adolescent Psychiatry, Medical University of Vienna Residency in Adolescent Psychiatry

EDUCATION AND TRAINING

23.05.2000 Department of Psychiatry & Psychotherapy, Medical University of Vienna

Habilitation Subject: Addiction research and therapy

10.10.1998 University of Vienna Graduation in hospital management and administration

from 1996 to 1998 University of Vienna Post gradual education in hospital management and administration

since 29.01.1995 Licenced medical specialist for Intensive Care

from 1986 to 1992 Psychotherapeutic education in Behavioural Therapy

since 1991 Licenced specialist as Psychiatrist & Neurologist

from 1989 to 1990 Department of Psychiatry & Psychotherapy, Medical University of Vienna Residency in Psychiatry

from 1987 to 1989 Washington University, Department of Psychiatry/Jewish hospital Medical School of St. Louis USA Visiting fellow; Research education in epidemiology basic neuroscience & statistics with focus in

addiction psychiatry & gender/sex aspects

from 1984to 1986 Department of Psychiatry & Psychotherapy, Medical University of Vienna Residency in Psychiatry

16.04.1984 University of Vienna Promotion Dr. med. Univ. Medical Degree

from 1978 to 1984 University of Vienna, Medical Department

Student

1978 High school Wels General qualification for university access

from 1974 to 1978 High school Wels

Student

Seite 3 – Lebenslauf von Fischer Gabriele

from 1970 to 1974 High school Stainach

Student

from 1966 to 1970 Elementary school Student

PERSONAL SKILLS

MOTHER TONGUE GERMAN

OTHER LANGUAGES

ENGLISH • understanding excellent

• reading excellent • speaking excellent

French

• understanding Good • reading adequate

• speaking adequate

ORGANISATIONAL & MANAGERIAL

SKILLS

since 2011 MINI MED Studies

Board member

since 1995 Organisation of training courses, meetings, workshops and conferences

from 16.07.2013 to 16.10.2013 Austrian Federal Ministry of Justice Task force of minister: imprisonment on remand for youth: prevention-reduction-execution

from 2008 to 2013 Medical University of Innsbruck Chair of University Board of Trustees www.i-med.ac.at

from 2003 to 2013 Medical University of Innsbruck Member of University Board of Trustees www.i-med.ac.at

from 2007 to 2010 Austrian Society for Gender Medicine Board member

from 1994 to 2003 University of Vienna, Medical faculty Member of the committee for gender equality

COMMUNICATION SKILLS

since 1990 Medical University of Vienna

Lecturer (Betrauungsdekret) Diagnostic und Therapy of addictive disorders Psychiatric and behavioural disorders related to psychotropic substances under consideration of

gender aspects Gender lectures MCW 20

since 1985 Lectures and presentations at national and international conferences

Seite 4 – Lebenslauf von Fischer Gabriele

since 1985

COMPUTER SKILLS

Scientific publications in national and international peer reviewed journals, book contributions and books

Word Power Point Excel SPSS

DRIVING LICENCE

Category A und B

ADDITIONAL INFORMATIONS

AWARDS

2008

Chimera Award, Sofia, Bulgaria

2007 Chimera Award, Pietrassanta, Italy

2000 CNS Research Award, Austrian Society for Neurology and Psychiatry, Supreme Award (founded

by Pfizer)

1998 University Vienna Award, Women’s Forum

MEMBERSHIP

Scientific Associations CPDD College on Problems of Drug Dependence ECNP European College of Neuropsychopharmacology European Methadone Association EPA-gender section: gender differences and substance use disorder IDHDP International Doctors of Healthy Drug Policies ISAM International Society of Addiction Medicine NEAR Network of Excellence in Addiction Research ÖGPP Austrian Society for Psychiatry & Psychotherapy Society for the Study of Addiction and Alcohol and Other Drugs

Scientific or Advisory Board Member of Austrian Medical Council

Scientific advisory board: Addiction und ADHD EUFAS European Federation of Addiction Societies Eureka Eurostars: Advisory board member for EU framework grants UNODOC

Technical consultant; treatment implementation for substance dependent women & children in Afghanistan

WHO Currently: Development on guidelines for diagnoses and treatment of substance dependence in pregnancy

WPA Section on Dual Disorders/Pathology

Editorial board Archives of Women´s Mental Health European Addiction Research European Neuropsychopharmacology Frontiers

Seite 5 – Lebenslauf von Fischer Gabriele

Heroin Addiction and Related Clinical Problems PLOS ONE Psychology of Addictive Behaviors Research Journal of Drug Abuse Suchtmedizin Suchttherapie Wiener Klinische Wochenschrift

Senior Editor Addiction

Associate Editor Frontiers in Pharmacology

Assistant Editor Addiction Cochrane European Addiction Research Frontiers in Clinical Trials and Pharmacotherapy

Reviewer Addiction Archives of General Psychiatry

British Medical Journal Drug and Alcohol Review Drug and Alcohol Dependence European Addiction Research European Journal of Clinical Investigation European Neuropsychopharmacology European Psychiatry International Journal of Psychiatry in Clinical Practice Journal of Psychopharmacology Pharmacopsychiatry Psychiatrie und Psychotherapie SPPE Social Psychiatry and Psychiatric Epidemiology Suchtmedizin in Forschung und Praxis Suchttherapie Wiener Klinische Wochenschrift Wiener Medizinische Wochenschrift And others

PROJECTS

EU Grants

2011 - 2014 REDUCE Project: Reducing hepatitis C sexual and drug taking risk behaviours among female

drug users in Europe: translating evidence into practice. European Commission, Directorate – General Justice. EU Contract Nr.: JLS/2009-2010/DPIP/AG/4000000975

2010 - 2011 Study on the Development of a EU Framework for minimum quality standards and benchmarks

in drug demand reduction. European Commission Directorate General Justice, Liberty and Security EU contract Nr.: JLS 2010/DPIR/PR/1023

2005 - 2010 EU Model of good practice in drug treatment in Europe – More Treat 6th framework program

EU contract Nr.: F32117831

2002 - 2004 Rose – Management of high risk opiate addicts 5th framework program EU contract Nr.: QLG4-CT-2002-01681

2002 - 2004 Cocaine – cocaine 5th framework program

EU Grant Nr.: QLGA-CT-2001-02301

Seite 6 – Lebenslauf von Fischer Gabriele

NIH Grants

2010 - 2013 Supplement: Developmental investigation on neonates exposed to buprenorphine vs. methadone NIH Grant Nr.: 1R01DA018417-01

2004 - 2010 MOTHER Maternal Opioid Treatment: Human Experimental Research; randomised, multicenter,

double-blind study to compare Methadone and Buprenorphine for treatment of opioid dependent women during their pregnancy and consequences on Neonatal Abstinence Syndrome (NAS) NIH Grant Nr.: 1R01 DA18417-01

Open Society Institute

August – November 2013 Substance abuse during pregnancy: prevention, detection and treatment. Network initiative

Funds by

Austrian National Bank

2009 - 2013 Pregnancy: Substance-related consequences for fetus and neonates

Anniversary Fund ÖNB Nr.: 13637

2006 – 2008 Quality of experience survey of opioid addicted patients in opioid maintenance therapy: Quality of life and mortality rate. ÖNB Nr.: 11650

2002 – 2005 Addiction and pregnancy: Evaluation of health related factors in neonates and their mothers

ÖNB Nr.: 9669

1996 – 1998 Brain - SPECT screening for substance dependence ÖNB Nr.: 5981

1996 - 1997 Buprenorphine/Methadone in opioid maintenance therapy

ÖNB Nr.: 5818

Mayor Funds

1997 - 1999 Buprenorphine opioid maintenance therapy in opioid addicted women Mayor Fund Nr.: 1475

1997 - 1998 Influence of methadone, morphine, buprenorphine and naltrexone on humoral and cellular

immune parameters in opioid addicted patients undergoing opioid maintenance therapy in comparison to heroin addicts Mayor Fund Nr.: 1450

1996 - 1997 Morphine maintenance in opioid dependent pregnant women

Mayor Fund Nr. 1334

Other third party funding projects

since 2013 Prevalence of adult attention deficit/hyperactivity disorder and comorbid psychiatric disorders in patients with substance use disorder or problematic gambling as well as non treatment-seeking gamblers.

since 2011 Development of a morphine-naloxone combination tablet: Phase II single centre double blinded

cross over dose confirmation study using two morphine-naloxone intravenous solutions

since 2011 Lifestyle survey with particular focus on eating behaviour in students

2008 Prevalence of substance use disorder in pathological gambling

2008 - 2010 A randomized open – label, multicenter, efficacy and safety study examining the effects of 24

Seite 7 – Lebenslauf von Fischer Gabriele

versus 48 weeks of combination therapy with Pegasys Peginterferon Alfa-2a 40 KD plus Copegus (Ribavarin) on Sustained virological response in patients with chronic Hepatitis C, Genotyp 2 or 3 who do not achieve a rapid viral response. (RO 25-8310 und RO 20-99-63)

2007 - 2008 Evaluation of switching opioid dependent patients to SuboxoneR. Acceptance, safety and

consequences for medication (PO 5444)

2008 Vienna research festival – „Addiction-parcours“

2006 - 2008 Prevalence of addictive disorders with focus on non-substance related dependence: sex/gender aspects and comorbidity.

2005 - 2008 Hepatitis C Genotyp 2/3 study ML17087; Randomised, multicentre study to compare efficiency

of pegylised interferon ALFA 2A (Peg-INF 2A) in combination with two different doses of Ribavirin in patients with chronic Hepatitis C Subtyp 2/3.

2005 - 2008 Quality assurance in the implementation of slow release oral morphine for

treatment of opioid dependence and involvement of general practitioners.

2004 - 2008 Webportal – substance use disorder – international comparison

2001 - 2003 Application of morphine with particular focus on interdisciplinary cooperation with general practitioners.

1996 - 2003 Educational Grants for production of various brochures and guidelines

2001 - 2002 Controlled application of buprenorphine with particular focus on gender aspects (Cooperation

with general practitioners)

2001 Controlled application of buprenorphine with particular focus on incorporation of general practitioners.

2000 Application of slow release oral morphine with particular focus on introduction.

2000 Application of slow release oral morphine in opioid addicted patients.

1999 - 2000 Comparison of efficiency and tolerance of morphinsulfate – Retardgranulat versus Methadone

(daily oral dosage)

Wien, am 10.03.2014